Larvol Delta - Black-Diamond-Therapeutics-Announces-FDA-Allowance-of-IND-Application-for-BDTX1535-A-MasterKey-Inhibitor-of-EGFR-for-the-Treatment-of-Gliobastoma-and-NonSmall-Cell-Lung-Cancer

BDTX-1535 - Black Diamond Therap

https://www.globenewswire.com/news-release/2022/01/11/2364676/0/en/Black-Diamond-Therapeutics-Announces-FDA-Allowance-of-IND-Application-for-BDTX-1535-A-MasterKey-Inhibitor-of-EGFR-for-the-Treatment-of-Gliobastoma-and-Non-Small-Cell-Lung-Cancer.html

Jan 11, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next